Disease prevalence mapping allows countries to identify infected individuals and populations in need of diseasecontrol measures, such as mass drug administration (MDA) with preventive chemotherapy. For countries with unlimited time and resources, diseasespecific prevalence mapping may be carried out in a slow, careful manner, by large teams of diagnostic technicians, supervisors, and drivers. These mapping protocols, established by the World Health Organization (WHO), are intended to be carried out independently, by each respective disease-control programme, in order to assess prevalence of neglected tropical diseases (NTDs) in individual populations. They work particularly well in areas endemic for one NTD.
In reality, the countries most affected by NTDs have limited resources for mapping, and are endemic for two or more NTDs, for example lymphatic filariasis (LF), and/or trachoma, and/or schistosomiasis and/or soil transmitted helminths (STH). For these countries, with efficiency and field-practicality in mind, the coordinated threshold mapping (CTM) method was developed. The method enables coordinators from two or more disease programmes to work together to determine the prevalence of two or more diseases in a population, at one time. The CTM method achieves the same goals as the WHO's disease-specific protocols, namely identifying the need for MDA with preventive chemotherapy. It does not provide prevalence figures, but instead aims to determine whether a disease has attained the threshold necessitating a public health intervention. 1 Therefore, rather than carrying out simultaneous, independent mapping efforts in areas endemic for more than two NTDs, at a high cost to the national control programmes, the CTM method saves countries precious time (smaller sampling size) and resources (fewer survey team members). Table 1 gives a comparison of disease-specific prevalence mapping and CTM.
It is the responsibility of a nationallevel coordinator to work together with the coordinators of the various NTD control programmes to compile historic data that will determine areas where NTDs are suspected to be endemic. Once the areas in need of NTD prevalence mapping have been identified, a protocol is agreed upon at the national level. In the CTM method, each disease module uses the WHO-recommended standard indicators and diagnostic methods (Table 2) , and is field-tested and independent. As such, a After giving stool and urine samples (to detect soil-transmitted helminths and schistosomiasis, respectively) the children are checked for signs of trachoma. tOGO The CTM team (supervisor and diagnostic technicians) travels in one vehicle to survey two villages in each subdistrict each day. Depending on which diseases are being mapped, some combination of the following activities takes place: trachoma examinations, stool collection, urinalysis, and LF testing (during the day) as well as examination of stool samples (Kato-Katz method) in the evening. Community health workers, teachers, and village chiefs are encouraged by the NTD control programme coordinators to assist with bringing participants to a central location, then organising and registering them. This participation of local volunteers has been shown to build local capacity and spontaneous local advocacy for co-ordinated NTD control. ; for LF, loiasis, schistosomiasis and STH in South Sudan 8, 9 , for trachoma, LF, schistosomiasis and STH in Mali and Senegal 1 ; and for schistosomiasis and STH in Cameroon. 10 Although CTM offers several important advantages over the WHO's diseasespecific protocol for countries that are endemic for more than one NTD, the method is not without shortcomings (Table 1) . However, the various NTD programmes share the common goal of a healthier, more productive population. By working together in disease mapping, this common goal is more attainable. In our experience, the initial reluctance towards collaboration among different NTD programmes was eased as members quickly noticed improved efficiency compared to disease-specific methodologies. Trichiasis present in ≥1% of adults (≥15 years old)
The prevalence of nodules is determined via the rapid epidemiological mapping method (REMO); or the presence of Onchocerca volvulus microfilaria is determined via skin snip 
